Ligand specific effects on aluminum incorporation and toxicity in neurons and astrocytes

Brain Research

Volumn 877, Issue 2, 2000, Pages 191-202

  Lévesque, Lyne ^a   Mizzen, Craig A ^b   McLachlan, Donald R ^a   Fraser, Paul E ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aluminum; Astrocyte; Cytotoxicity; Neurons

Indexed keywords

ALUMINUM; ALUMINUM CHLORIDE; ALUMINUM FLUORIDE; ALUMINUM LACTATE; ALUMINUM MALTOL; CATHEPSIN D;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL VIABILITY; CONTROLLED STUDY; GLIA CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; WATER MANAGEMENT;

ALUMINUM COMPOUNDS; ANIMAL; ASTROCYTES; BRAIN; CELL COMPARTMENTATION; CELLS, CULTURED; CHLORIDES; ENVIRONMENTAL EXPOSURE; FLUORIDES; INTRACELLULAR FLUID; LACTATES; LIGANDS; MICE; NEURONS; NEUROTOXINS; ORGANOMETALLIC COMPOUNDS; PYRONES; RATS; SUPPORT, NON-U.S. GOV'T;

EID: 0343714604     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02637-8     Document Type: Article

References (67)

1. Albrecht J., Simmons M., Dutton G.R., Norenberg M.D. Aluminum chloride stimulates the release of endogenous glutamate, taurine and adenosine from cultured rat cortical astrocytes. Neurosci. Lett. 127:1991;105-107.
2. Alfrey A.C., Gary R., LeGendre G.R., Kaehny W.D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N. Engl. J. Med. 294:1976;184-188.
3. Anane R., Bonini M., Grafeille J.-M., Creppy E.E. Bioaccumulation of water soluble aluminum chloride in the hippocampus after transdermal uptake in mice. Arch. Toxicol. 69:1995;568-571.
4. Bates S.R., Pennington J. Aluminum activation of 'immediate early' gene expression in Swiss 3T3 fibroblasts. Biochem. Soc. Trans. 24:1996;499S.
5. Baydar T., Sahin G., Aydin A., Isimer A., Akalin S., Duru S. Al/Cr ratio in plasma and urine of diabetics. Trace Elem. Electrolytes. 13:(1):1996;50-53.
6. Berthon G. Relevance of aluminum-acid complex equilibria to aluminum bioavailability. Anastassopoulou J., Collery Ph., Etienne J.C., Theophanides Th. Metals in Biology and Medicine. Vol. 2 :1992;pp. 253-258 The John Libbey Eurotext, Paris.
7. Bigay J., Deterre P., Pfister C., Chabre M. Fluoride complexes of aluminum or beryllium act on G-proteins as reversibly bound analogues of the (Gamma) phosphate of GTP. EMBO J. 6:(10):1987;2907-2913.
8. Bizzi A., Gambetti P. Phosphorylation of neurofilaments is altered in aluminum intoxication. Acta Neuropathol. 71:1986;154-158.
9. Burwen D.R., Olsen S.M., Bland L.A., Arduinao M.J., Reid M.H., Jarvis W.R. Epidemic aluminum intoxication in hemodialysis patients traced to use of an aluminum pump. Kidney Int. 48:1995;469-474.
10. Candy J.M., McArthur F.K., Oakley A.E., Taylor G.A., Chen C.P.L.H., Mountfort S.A., Thompson J.E., Chalker P.R., Bishop H.E., Beyreuther K., Perry G., Ward M.K., Martyn C.N., Edwardson J.A. Aluminum accumulation in relation to senile plaque and neurofibrillary tangle in the brains of patients with renal failure. J. Neurol. Sci. 107:1992;210-218.
11. Cashman N.R., Durham H.D., Blutztajn J.K., Oda K., Tabira T., Shaw I.T., Darhouge S., Antel J. Neuroblastoma X spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dynamics. 194:1992;209-221.
12. Clauberg M., Joshi J.G. Regulation of serine protease activity by aluminum: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1009-1012.
13. Cochran M., Coates J., Neoh S. The competitive equilibrium between aluminum and ferric ions for the binding sites of transferrin. FEBS Lett. 176:1984;129-132.
14. Codina J., Birnbaumer L. Requirement for intramolecular domain interaction in activation of G protein alpha subunit by aluminum fluoride and GDP but not by GTP gamma S. J. Biol. Chem. 269:(47):1994;29339-29342.
15. Crapper D.R., Krishnan S.S., Dalton A.J. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science. 180:1973;511-513.
16. Crapper D.R., Quittkat S., Krishnan S.S., Dalton A.J., DeBoni U. Intranuclear content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathol. 50:1980;19-24.
17. De Boni U., Scott J., Crapper D.R. Intracellular aluminum binding; a histochemical study. Histochemistry. 40:1974;31-37.
18. Deleers M., Servais J.-P., Wülfert E. Neurotoxic cations induce membrane rigidity and membrane fusion at micromolar concentrations. Biochem. Biophys. Acta. 855:1986;271-276.
19. Donaldson J.D., Kahn R.A., Lippincott-Schwartz J., Klausner R.D. Binding of ARF and βCOP to Golgi membranes: possible regulation by a trimeric G protein. Science. 254:1991;1197-1199.
20. Favarato M., Mizzen C.A., Sutherland M.K., Krishnan B., Kruck T.P.A., Crapper McLachlan D.R. Aluminum-binding serum proteins: desferrioxamine alters serum aluminum speciation. Clin. Chem. Acta. 207:1992;41-45.
21. Fernandez-Menéndez M.J., Olaizola I.R., Diaz-López J.B., Fernandez-Soto I., Roza M., Cannata J.B. A double risk of aluminum hydroxide: increased aluminum uptake and reduced iron absorption. Trace Elem. Med. 8:(4):1991;167-171.
22. Finazzi D., Cassel D., Donaldson J.D., Klausner R.D. Aluminum fluoride acts on the reversibility of ARF1-dependent coat protein binding to Golgi membranes. J. Biol. Chem. 269:(18):1994;13325-13330.
23. Finnegan M.M., Rettig S.J., Orvig C. A neutral water-soluble aluminum complex of neurological interest. J. Am. Chem. Soc. 108:1986;5033-5035.
24. Flendrig J.A., Kruis H., Das H.A. Aluminum and dialysis dementia. Lancet. 1:1976;1235.
25. Forbes W.F., Agwani N. A suggested mechanism for aluminum biotoxicity. J. Theor. Biol. 171:1994;207-214.
26. Forbes W.F., Gentleman J.F., Maxwell C.J. Concerning the role of aluminum in causing dementia. Exp. Gerontol. 30:(1):1995;23-32.
27. Greger J.L., Sutherland J.E. Aluminum exposure and metabolism. Crit. Rev. Clin. Lab. Sci. 34:(5):1997;439-474.
28. Harrington C.R., Wischik C.M., McArthur F.K., Taylor G.A., Edwardson J.A., Candy J.M. Alzheimer's disease-like changes in tau protein processing: association with aluminum accumulation in brains of renal dialysis patients. Lancet. 343:1994;993-997.
29. Hironishi M., Kordek R., Yanagihara R., Garruto R. Maltol (3-hydroxy-2-methyl-4-pyrone) toxicity in neuroblastoma cell lines and primary murine fetal hippocampal neuronal cultures. Neurodegeneration. 5:1996;325-329.
30. 1-antichymotrypsin and ubiquitin-protein conjugates. Brain Res. 771:1997;213-220.
31. Jagannatha Rao K.S. Effect of aluminum (Al) on the brain cells of the rat. Biochem. Int. 28:(1):1992;51-56.
32. Kleber C.J., Putt M.S. Aluminum and dental carries. A review of the literature. Clin. Prev. Dent. 6:1984;14-25.
33. Leterier J.F., Langui D., Probst A., Ulrich J. A molecular mechanism for the induction of neurofilament bundling by aluminum ions. J. Neurochem. 58:1992;2060-2070.
34. L. Lévesque, W. Annaert, K. Craessaerts, P.M. Mathews, M. Seeger, R.A. Nixon, F. Van Leuven, S. Gandy, D. Westaway, P. St George-Hyslop, B. De Strooper, P.E. Fraser, Developmental expression of wild-type and mutant presenilin-1 in hippocampal neurons from transgenic mice evidence for novel species-specific properties of human presenilin-1, Mol. Med. 5 (1999) 542-554.
35. Lukiw W.J. Aluminum and gene transcription in Alzheimer's disease and related neurodegenerative disorders. J. Trace Elem. Exp. Med. 11:1998;419-420.
36. Lukiw W.J., Krishnan B., Wong L., Kruck T.P., Bergeron C., Crapper McLachlan D.R. Nuclear compartmentalization of aluminum in Alzheimer's disease (AD). Neurobiol. Aging. 13:1992;115-121.
37. Lukiw W.J., McLachlan D.R. Neurotoxicology of aluminum. Chang L., Dyer R. II: Effects and Mechanisms. Handbook of Neurotoxicology. vol. 4:1995;105-142 Marcel Dekker, New York.
38. Lukiw W.J., Leblanc H.J., Carver L.A., McLachlan D.R., Bazan N.G. Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative diseases. J. Mol. Med. 11:(1):1998;67-78.
39. Martin R.B. The chemistry of aluminum as related to biology and medicine. Clin. Chem. 32:(10):1986;1797-1806.
40. Martin R.B. Aluminum in biological systems. Nicolini M., Zatta P.F., Corain B. Aluminum in Chemistry, Biology and Medicine. 1991;pp. 3-20 Raven Press, New York.
41. McLachlan D.R.C., Bergeron C., Smith J.E., Boomer D., Rifat S.L. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology. 46:1996;401-405.
42. Mendenhall W., McClave J.T., Ramey M. Statistics for psychology. 2nd Ed :1977;Duxbury Press, North Scituate, Massachussets.
43. Mesco E.R., Kachen C., Timiras P.S. Effect of aluminum on tau proteins in human neuroblastoma cells. Mol. Chem. Neuropathol. 14:1991;199-226.
44. Morris C.M., Candy J.M., Court J.A., Whitford C.A., Edwardson J.A. The role of transferrin in the uptake of aluminum and manganese by the IMR32 neuroblastoma cell line. Biochem. Soc. Trans. 15:1987;498.
45. Mundy W.R., Freudenrich T.M., Kodavanti P.R.S. Aluminum potentiates glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures. Mol. Chem. Neuropathol. 32:1997;41-57.
46. Muma N.A., Troncoso J.C., Hoffman P.N., Koo E.H., Price D.L. Aluminum neurotoxicity: altered expression of cytoskeletal genes. Mol. Brain Res. 3:1988;115-122.
47. Nixon R.A., Clarke J.F., Logvinenko K.B., Tan M.K.H., Hoult M., Grynspan F. Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes. J. Neurochem. 55:1990;1950-1959.
48. Ogoshi K., Yanagi S., Moriyama T., Arachi T. Accumulation of aluminum in cancers of the liver, stomach, duodenum and mammary glands of rats. J. Trace Elem. Electrolytes Health Dis. 8:1994;27-31.
49. 2+-initiated lipid peroxidation in phospholipid liposomes by a lipophilic aluminum complex, aluminum acetylacetonate. Biochem. Biophys. Acta. 1389:1998;141-149.
50. Perl D.P., Brody A.R. Alzheimer's disease: x-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science. 208:1980;297-299.
51. Priest N.D., Newton D., Day J.P., Talbot R.J., Warner A.J. Human metabolism of aluminum-26 and gallium-67 injected as citrates. Human Exp. Toxicol. 14:1995;287-293.
52. Radany E.H., Brenner M., Besnard F., Bigornia V., Bishop J.M., Deschepper C.F. Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes. Proc. Natl. Acad. Sci. USA. 89:(14):1992;6467-6471.
53. Savory J., Herman M.M., Hundley J.C., Seward R.L., Griggs G.M., Katsetos C.D., Wills M.R. Quantitative studies on aluminum deposition and its effects on neurofilament protein expression and phosphorylation, following the intraventricular administration of aluminum maltolate to adult rabbits. Neurotoxicology. 14:(1):1993;9-12.
54. Savory J., Huang Y., Herman M.M., Reyes M.R., Mills M.R. Tau immunoreactivity associated with aluminum maltolate-induced neurofibrillary degeneration in rabbits. Brain Res. 669:1995;325-329.
55. Shea T.B., Balilian P., Beermann M.L. Aluminum inhibits neurofilament protein degradation by multiple cytoskeleton-associated proteases. FEBS Lett. 307:(2):1992;195-198.
56. Shea T.B., Clarke J.F., Weelock T.R., Paskevich P.A., Nixon R.A. Aluminum salts induce the accumulation of neurofilaments in perikarya of NB2a/dl neuroblastoma. Brain Res. 492:1989;53-64.
57. Shetty K.T., Veeranna, Guru S.C. Phosphatase activity against neurofilament proteins from bovine spinal cord: effect of aluminum and neuropsychoactive drugs. Neurosci. Lett. 137:1992;83-86.
58. Shi B., Haug A. Aluminum uptake by neuroblastoma cells. J. Neurochem. 55:1990;551-558.
59. Shigematsu K., McGeer P.L. Accumulation of amyloid precursor protein in damaged neuronal process and microglia following intracerebral administration of aluminum salts. Brain Res. 593:1992;117-123.
60. Shin R.-W., Lee V.M.-Y., Trojanowski J.Q. Aluminum modifies the properties of Alzheimer's disease PHFτ proteins in vivo and in vitro. J. Neurosci. 14:(11):1994;7221-7233.
61. Suárez-Fenández M.B., Soldaldo A.B., Sanz-Medel A., Vega J.-A., Novelli A., Fernández-Sánchez M.T. Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res. 835:1999;125-136.
62. Uemura E., Minachi M., Lartius R. Enhanced neurite growth in cultured neuroblastoma cells exposed to aluminum. Neurosci. Lett. 142:1992;171-174.
63. Van Ginkel M.F., Van der Voet G.B., D'Haese P.C., De Broe M.E., De Wolfe F.A. Effect of citric acid and maltol on the accumulation of aluminum in rat brain and bone. J. Lab. Clin. Med. 121:1993;453-460.
64. Wittinghofer A. Signaling mechanistics: aluminum fluoride for molecule of the year. Curr. Biol. 7:1997;R682-R685.
65. Yang E.Y., Guo-Ross S.X., Bondy S.C. The stabilization of ferrous iron by a toxic β-amyloid fragment and by an aluminum salt. Brain Res. 839:1999;221-226.
66. Yasui M., Kihira T., Ota K. Calcium, magnesium and aluminum concentrations in Parkinson's disease. NeuroToxicology. 13:1992;593-600.
67. Zapatero M.D., deJalon A.G., Pascual F., Calvo M.L., Escanero J., Marro A. Serum aluminum levels in Alzheimer's disease and other senile dementias. Biol. Trace Elem. Res. 47:1995;235-240.